Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Pre-Clinical Data On OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting In Brain Tissue
OmniGuide, Inc., the developer of the first and only flexible CO2 laser fiber based on breakthrough photonic bandgap technology, announced the results of a pre-clinical study comparing the Company"s fiber scalpels to conventional incision methods in neurosurgery. In the study, surgeons from the Barrow Neurological Institute reported that careful studies of incisions produced in live brain tissue with fiber delivered CO2 laser radiation produced precise cuts while minimally effecting adjacent brain tissue when compared with a widely used reference technique. The study, led by Drs. Mark Preul, Robert W. Ryan, and Robert Spetzler of the Neurosurgery Research Laboratory, Barrow Neurological Institute, in Phoenix, Arizona, was presented at the annual conference of the American Academy of Neurological Surgeons in San Diego, California.

Hot Flashes May Prompt Closer Look At Bone Health
A new study, published in the journal Menopause, found postmenopausal women with vasomotor symptoms-which include hot flashes and night sweats-had lower bone mineral density in the spine and hip.
News of the day
Rates Of Severe Childhood Obesity Have Tripled
Rates of severe childhood obesity have tripled in the last 25 years, putting many children at risk for diabetes and heart disease, according to a report in Academic Pediatrics by an obesity expert at Brenner Children"s Hospital, part of Wake Forest University Baptist Medical Center.
Health Insurance

Which? Warns Consumers Against Costly Genetic Tests

As the Lords Science Committee publishes its report on genomic medicine, Which? scientific policy adviser, Dr Rob Reid, says: "It has to be made clear to consumers that these tests are no more useful in predicting disease than knowledge of their family history and lifestyle. People could end up spending a lot of money on information* that is currently of little medical use." Notes *Genetic susceptibility tests sold direct to the consumer. Which? welcomes the publication of the House of Lords Science and Technology Committee"s wide ranging and detailed report on Genomic Medicine. In particular Which? is delighted that the report acknowledges the potential for consumer detriment caused by direct-to-consumer genetic susceptibility testing. Which? supports the recommendations that a voluntary code for the industry be established and that the UK government should support tougher classification of the tests at EU level. Peer reviewed scientific research has demonstrated that there is currently not enough evidence to show that genetic susceptibility tests are useful in measuring genetic risk for common diseases. However, Which? research found that 86% of all adults asked said they would take or consider taking further action if a genetic susceptibility test suggested they were more likely to develop a disease. Despite these findings there is currently little regulation of the sale of genetic susceptibility tests direct-to-the-consumer. Which?


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009